TAK ALG-25 (Nesina 25 mg)
Generic Name: alogliptin
Pill with imprint TAK ALG-25 is Red, Elliptical / Oval and has been identified as Nesina 25 mg. It is supplied by Takeda Pharmaceuticals America, Inc..
Nesina is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Nesina 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for TAK ALG-25
Nesina
- Generic Name:
- alogliptin
- Imprint:
- TAK ALG-25
- Strength:
- 25 mg
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Takeda Pharmaceuticals America, Inc.
- National Drug Code (NDC):
- 64764-0250
More about Nesina (alogliptin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: dipeptidyl peptidase 4 inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
